Standing Alone While Standing Together: A Conversation With Millennium CEO Dunsire (Part 2 Of 2)
This article was originally published in PharmAsia News
Executive SummaryMillennium Pharmaceuticals reached its one-year anniversary as the Takeda Oncology Company on May 14. Millennium Pharmaceuticals CEO Deborah Dunsire sat down recently with "The Pink Sheet" DAILY for a conversation about the changes seen in that first year.
You may also be interested in...
"A Quantum Leap In Resources": Millennium CEO Dunsire In A Conversation On The Firm's First Year As Part Of Takeda (Part 1 Of 2)
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).